| MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses … S Jarius, K Ruprecht, I Kleiter, N Borisow, N Asgari, K Pitarokoili, F Pache, ... Journal of neuroinflammation 13, 1-45, 2016 | 923 | 2016 |
| Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients S Jarius, K Ruprecht, B Wildemann, T Kuempfel, M Ringelstein, C Geis, ... Journal of neuroinflammation 9, 1-17, 2012 | 881 | 2012 |
| MOG encephalomyelitis: international recommendations on diagnosis and antibody testing S Jarius, F Paul, O Aktas, N Asgari, RC Dale, J De Seze, D Franciotta, ... Journal of neuroinflammation 15, 1-10, 2018 | 791 | 2018 |
| MRI characteristics of neuromyelitis optica spectrum disorder: an international update HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ... Neurology 84 (11), 1165-1173, 2015 | 662 | 2015 |
| Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS) C Trebst, S Jarius, A Berthele, F Paul, S Schippling, B Wildemann, ... Journal of neurology 261, 1-16, 2014 | 658 | 2014 |
| Trial of satralizumab in neuromyelitis optica spectrum disorder T Yamamura, I Kleiter, K Fujihara, J Palace, B Greenberg, ... New England Journal of Medicine 381 (22), 2114-2124, 2019 | 597 | 2019 |
| Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, B Wegner, ... Annals of neurology 79 (2), 206-216, 2016 | 439 | 2016 |
| Myelin-oligodendrocyte glycoprotein antibody-associated disease R Marignier, Y Hacohen, A Cobo-Calvo, AK Pröbstel, O Aktas, ... The Lancet Neurology 20 (9), 762-772, 2021 | 434 | 2021 |
| MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association … S Jarius, K Ruprecht, I Kleiter, N Borisow, N Asgari, K Pitarokoili, F Pache, ... Journal of neuroinflammation 13, 1-16, 2016 | 433 | 2016 |
| Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures S Jarius, F Paul, D Franciotta, K Ruprecht, M Ringelstein, R Bergamaschi, ... Journal of the neurological sciences 306 (1-2), 82-90, 2011 | 402 | 2011 |
| Demographic and clinical features of neuromyelitis optica: a review L Pandit, N Asgari, M Apiwattanakul, J Palace, F Paul, MI Leite, I Kleiter, ... Multiple Sclerosis Journal 21 (7), 845-853, 2015 | 350 | 2015 |
| Failure of natalizumab to prevent relapses in neuromyelitis optica I Kleiter, K Hellwig, A Berthele, T Kümpfel, RA Linker, HP Hartung, F Paul, ... Archives of neurology 69 (2), 239-245, 2012 | 344 | 2012 |
| Pegylated liposomal doxorubicin‐efficacy in patients with recurrent high‐grade glioma P Hau, K Fabel, U Baumgart, P Rümmele, O Grauer, A Bock, C Dietmaier, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 250 | 2004 |
| MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement-frequency, presentation and outcome S Jarius, I Kleiter, K Ruprecht, N Asgari, K Pitarokoili, N Borisow, ... Journal of neuroinflammation 13, 1-23, 2016 | 248 | 2016 |
| Long-term therapy with interleukin 6 receptor blockade in highly active neuromyelitis optica spectrum disorder M Ringelstein, I Ayzenberg, J Harmel, AS Lauenstein, E Lensch, ... JAMA neurology 72 (7), 756-763, 2015 | 246 | 2015 |
| Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy I Ayzenberg, I Kleiter, A Schröder, K Hellwig, A Chan, T Yamamura, ... JAMA neurology 70 (3), 394-397, 2013 | 240 | 2013 |
| Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical … O Grauer, D Wolff, H Bertz, H Greinix, JS Kühl, A Lawitschka, SJ Lee, ... Brain 133 (10), 2852-2865, 2010 | 228 | 2010 |
| Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, K Hellwig, ... Neurology: Neuroimmunology & Neuroinflammation 5 (6), e504, 2018 | 222 | 2018 |
| Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease F Leypoldt, R Buchert, I Kleiter, J Marienhagen, M Gelderblom, T Magnus, ... Journal of Neurology, Neurosurgery & Psychiatry 83 (7), 681-686, 2012 | 203 | 2012 |
| Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders S Jarius, C Jacobi, J de Seze, H Zephir, F Paul, D Franciotta, P Rommer, ... Multiple Sclerosis Journal 17 (9), 1067-1073, 2011 | 189 | 2011 |